Regulatory Perspectives for 3D Printing in Hospitals

Andy Christensen; Nicole Wake

doi:10.1016/B978-0-323-77573-1.00015-4

Regulatory Perspectives for 3D Printing in Hospitals

Andy Christensen, Nicole Wake

Radiology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

2 Scopus citations

Abstract

The United States (US) Food and Drug Administration (FDA) has overseen medical device marketing in the US since 1976. Although the FDA regulates the medical device industry which designs, manufactures, and sells medical devices to physicians and hospitals, the FDA does not typically regulate hospitals or individual physicians. This chapter will review medical device classifications according to the FDA and will discuss regulatory considerations for hospitals creating 3D printed medical devices at the point of care.

Original language	English (US)
Title of host publication	3D Printing for the Radiologist
Publisher	Elsevier
Pages	109-116
Number of pages	8
ISBN (Electronic)	9780323775731
DOIs	https://doi.org/10.1016/B978-0-323-77573-1.00015-4
State	Published - Jan 1 2021

Keywords

FDA
Liability
Point of care
Practice of medicine
Regulation

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/B978-0-323-77573-1.00015-4

Cite this

@inbook{726248d34aa94756bc6ec15315150d07,

title = "Regulatory Perspectives for 3D Printing in Hospitals",

abstract = "The United States (US) Food and Drug Administration (FDA) has overseen medical device marketing in the US since 1976. Although the FDA regulates the medical device industry which designs, manufactures, and sells medical devices to physicians and hospitals, the FDA does not typically regulate hospitals or individual physicians. This chapter will review medical device classifications according to the FDA and will discuss regulatory considerations for hospitals creating 3D printed medical devices at the point of care.",

keywords = "FDA, Liability, Point of care, Practice of medicine, Regulation",

author = "Andy Christensen and Nicole Wake",

year = "2021",

month = jan,

day = "1",

doi = "10.1016/B978-0-323-77573-1.00015-4",

language = "English (US)",

pages = "109--116",

booktitle = "3D Printing for the Radiologist",

publisher = "Elsevier",

}

TY - CHAP

T1 - Regulatory Perspectives for 3D Printing in Hospitals

AU - Christensen, Andy

AU - Wake, Nicole

PY - 2021/1/1

Y1 - 2021/1/1

N2 - The United States (US) Food and Drug Administration (FDA) has overseen medical device marketing in the US since 1976. Although the FDA regulates the medical device industry which designs, manufactures, and sells medical devices to physicians and hospitals, the FDA does not typically regulate hospitals or individual physicians. This chapter will review medical device classifications according to the FDA and will discuss regulatory considerations for hospitals creating 3D printed medical devices at the point of care.

AB - The United States (US) Food and Drug Administration (FDA) has overseen medical device marketing in the US since 1976. Although the FDA regulates the medical device industry which designs, manufactures, and sells medical devices to physicians and hospitals, the FDA does not typically regulate hospitals or individual physicians. This chapter will review medical device classifications according to the FDA and will discuss regulatory considerations for hospitals creating 3D printed medical devices at the point of care.

KW - FDA

KW - Liability

KW - Point of care

KW - Practice of medicine

KW - Regulation

UR - http://www.scopus.com/inward/record.url?scp=85127702438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85127702438&partnerID=8YFLogxK

U2 - 10.1016/B978-0-323-77573-1.00015-4

DO - 10.1016/B978-0-323-77573-1.00015-4

M3 - Chapter

AN - SCOPUS:85127702438

SP - 109

EP - 116

BT - 3D Printing for the Radiologist

PB - Elsevier

ER -

Regulatory Perspectives for 3D Printing in Hospitals

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this